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Abstract
Vaccine hesitancy is often understood and explored on the level of individual decision-making. However, 
questions surrounding the risk and efficacy of vaccination are evident in wider public discourse; social 
narratives of vaccination inform and impact on the individual level. This paper takes a narrative analysis 
approach from the sociology of health to examine data drawn from a wider study on global public health 
responses to the H1N1 pandemic. The paper concentrates upon criticisms to mass vaccination as recounted 
within the Council of Europe’s debate of the handling of H1N1. It shows that three narratives were particularly 
dominant: problematizing the use of vaccination as a public health response; criticising the efficacy of the 
vaccines; and, questioning the safety of the strategy. This debate presents an important case study in 
understanding the way in which vaccines are problematized within the public discourse.
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Introduction
Mass vaccination has been widely recognised as a key public health achievement. However, vaccine hesitancy – 
bound up in uncertainty or lack of confidence in the safety and effectiveness of vaccination – may serve to 
undermine comprehensive coverage. Vaccine hesitancy is often examined on the scale of individual decision-
making, or through referring to questions of ethics and freedom of choice. However, when considering the 
problem of vaccine hesitancy, social scientists of medicine would note that the public discourse surrounding 
vaccines – the way in which vaccines are represented and publicly understood – forms another important piece 
of the puzzle. It is not just individuals, but rather wider social representations of vaccination, which underpin 
vaccine hesitancy. Individual ‘choices’ are produced in the context of narratives and public conversations about 
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the efficacy and safety of vaccine use. The ways in which vaccines are described and discussed in the public 
domain impacts upon private decision-making. Understanding these narratives is therefore pivotal to the wider 
understanding of the problem of vaccine hesitancy.
This paper examines the case study of the Council of Europe’s public criticism of mass vaccination during the 
H1N1 Influenza Pandemic. In December 2009, Council of Europe parliamentarian and epidemiologist Wolfgang 
Wodarg presented a recommendation to the Council of Europe entitled ‘Faked Pandemics: A Threat to Public 
Health’.1 Following subsequent months of debate, the Council of Europe passed a motion decrying the WHO’s 
public health reaction to H1N1. Criticism of the H1N1 vaccine was central to these findings. Such contestations 
can have an important effect on the public discourse, for example through media attention and public 
discussion of vaccination. The Council of Europe’s criticisms were a source of extended media commentary, and 
public scrutiny over the use of vaccines during the H1N1 pandemic continues. This paper draws upon social 
scientific analyses of vaccine narratives and illustrates the ways in which the Council of Europe’s account of 
H1N1 vaccines both reflected and influenced the wider societal discourses on vaccine uptake.
This paper utilises narrative analysis from the sociology of health to draw out the way in which vaccines were 
discussed and criticised. Narrative analysis allows for the identification of ideological and discursive 
constructions,2 including constructions surrounding the social ‘reality’ underpinning vaccine use. Narrative 
texts, as linguistic and discursive processes, are of fundamental importance in forming subjectivities and 
making the social world intelligible to those who live in it.2 The analysis of texts is important in understanding 
representations of disease, as narrative texts both present and constitute cultural interpretations of reality,3
providing insight into the social discourse underpinning this phenomena. The narratives and quotes discussed 
here are drawn out of a wider project which examined the global health management of the 2009-2010 H1N1 
Pandemic. As part of this, a comprehensive analysis was made of all publicly available documents produced and 
published through the course of the Council of Europe’s discussions surrounding the WHO’s management of 
H1N1. This paper particularly utilises data gleaned from the textual analysis of expert testimony, parliamentary 
debates, parliamentary reports, and documents produced by the Council of Europe during their examination of 
the World Health Organization’s management of the H1N1 Pandemic, focussing on statements concerning the 
use or misuse of vaccines in combating H1N1.
Sociological analyses of vaccine resistance and hesitancy can be dated from Stern’s4 key early work in the 
sociology of vaccine uptake, which articulates the irrational motives, beliefs, and the vested interests of those 
who resist the use of vaccines. Critical to this field is the idea that, as Hobson-West5 rightly notes, vaccine 
resistance is a communal activity. Although vaccine resistance and hesitancy is made up of individual acts of 
refusal or uncertainty, resistance itself is found in the ‘anti-vaccination movements’, as structured social 
movements as well as contemporary social norms of ‘questioning’ vaccines.6 The voices of counter-vaccination 
can often be heard through the media, particular patient advocacy groups, and public discussions of the harms 
of immunization. Dew7 suggests that narratives surrounding vaccines which run counter to the public health 
discourse are generally rooted in scepticism of science, and may include: the fact that medical practice is held 
in suspicion due to inherent uncertainty and iatrogenesis; concerns over the competence, experience, or 
interest of individual medical practitioners, and; concerns over the side-effects of vaccination. The Council of 
Europe’s public discussion of the H1N1 vaccine contained elements of each of these common tropes. In 
particular, concerns over safety and side-effects formed substantial components of the arguments developed by 
the Council of Europe critics. However, additional arguments – which may also be seen as recurring themes 
within the counter-vaccine discourse – were also evident in this case.
The narratives that marked the case of the Council of Europe’s criticism of H1N1 vaccines were the following: 
1.) Arguments surrounding trust and the decision to utilise mass vaccination as a public health tool in the case 
of H1N1; 2.) Criticisms of the efficacy of the vaccines themselves, including scepticism of the efficiency of 
vaccines in general, and the H1N1 vaccine in particular; and 3.) Questions surrounding the safety of these 
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vaccines. Understanding these narratives can lead to a greater appreciation of ways in which the public health 
community can address vaccine hesitancy.
Trust and Vaccination as an Effective Public Health Response
Scepticism or concern about vaccination is bound in problems of trust and mistrust. At the individual level, as 
Dew7 notes, this involves a particular patient’s trust in their medical practitioner, or in ‘medicine’ as a broader 
institution. The question of trust was also central to the Council of Europe’s contestation of H1N1 vaccination. In 
the case of the H1N1 pandemic, the Council of Europe argued that the World Health Organization was 
responsible for proposing vaccines as a management strategy. Rather than problematising trust in medicine or 
medical professionals, this case shows the problematisation of trust in public health structures and the World 
Health Organization.
For the WHO, influenza vaccination was understood as a pivotal public health strategy. Early mistrust in the 
H1N1 vaccines were regarded by the WHO as a problem given that, as the Special Advisor for Pandemic 
Influenza and Deputy Director-General Keiji Fukuda stated: ‘vaccines are really one of the prevention methods 
against infectious diseases which is best in terms of efficacy, [and] the safest’.8,7 Given concerns that, as one 
member of the press put it to Marie-Paul Keiny, WHO Director of the Initiative for Vaccine Research, ‘the [H1N1] 
vaccination campaign could actually create problems for the reputation of vaccines’9 the WHO strove to 
emphasise the safety and efficacy of H1N1 vaccines. The WHO upheld the dominant public health discourse 
surrounding the efficacy of vaccination.
The criticisms of the Council of Europe actors highlighted the problem of trusting the WHO. It was suggested by 
Paul Flynn (Council of Europe Rapporteur on the matter of the handling of H1N1), Hancock (representative for 
the UK), and Wodarg, that the WHO acted in an untrustworthy manner in having ‘cried wolf’10,11,12 over H1N1, 
and the ‘credibility’ and ‘accountability’ of the WHO had been undermined by the affair1,16, which was 
considered to be just one of ‘a whole series of scares’.12 These narratives were underpinned by the major 
political concern that the Council of Europe’s criticisms were addressing – that the mass vaccination campaign 
had been costly, since as Frahm (representative for Denmark) put it, the WHO’s recommendation had ‘forced 
countries to spend billions on unnecessary supplies’10 of antivirals and vaccines.
For the Council of Europe, the WHO’s decisions (and lack of credibility) had been a direct result of influence by 
pharmaceutical manufacturers. It was argued that the costly vaccination campaign had merely served to profit 
vaccine makers and that industry was able to ‘directly influence’ public health decisions surrounding H1N1.11 It 
was argued that there was ‘great commercial pressure’ to manage the H1N1 through the use of vaccines and 
other pharmaceuticals,11 and that ‘who pays the piper calls the tune’.16
Scepticism over the motives of key actors – the WHO and the producers of vaccines – was a key narrative. 
Action surrounding the H1N1 Pandemic reflected the globalised and rapid action surrounding the pandemic 
threat (as an urgent global problem, rather than scheduled vaccination regimes), and thus centred upon the 
role of the WHO. However, the issue of trust and accountability is more widely evident in issues of vaccine 
hesitancy. For instance, the Council of Europe actors’ scepticism was bound in concern of the greed and 
corruption of vaccine manufacturers. The concept of profit motives undermining the efficacy and safety of 
vaccines is recurring discourse in debates surrounding vaccine use.17 Building trust, not just in terms of 
scientific objectivity but in terms of wider institutional structures, is therefore fundamental to perceptions 
surrounding vaccination.
The Efficacy of Vaccination
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There is now a wide literature within the social sciences suggesting that the perception and management of risk 
is central to contemporary life at both the societal and the individual level.18,19 The notion of risk is particularly 
key to the issue of vaccine hesitancy – here, a lack of vaccine uptake is a choice (rather than a problem of lack 
of access), and this choice is underpinned by an understanding of the relative advantages and disadvantages of 
vaccine use. In assessing the benefits of vaccination, questions of efficacy are central. One of the ways in which 
vaccines are problematized is through challenging notions of efficacy, either at the general level or in regard to 
a particular type of vaccination. Such narratives of (in)efficacy were central to the Council of Europe actors’ 
representation of the H1N1 vaccination campaign.
The Council of Europe critics contested the need for administering vaccination against H1N1. The decision to 
undertake a mass immunisation campaign against the pandemic strain was decried as ‘without sufficient 
justification’ and unnecessary (Circene, representative for Latvia).10 This suggestion was reinforced – with the 
benefit of hindsight – by comparisons between countries that undertook vaccination and those that did not. So 
for example, it was argued that ‘[t]he country that spent the least was Poland, which rejected the idea that this 
disease was dangerous and which has suspicions about the safety of the vaccine…’ where, compared the 
Britain’s comparatively larger spending on pharmaceuticals ‘…the number of deaths per million from swine flu 
in Britain was about twice the number in Poland’ (Flynn).10 It was suggested that vaccination was therefore not 
an effective public health response to H1N1.
In addition to specific criticisms of the efficacy of the H1N1 vaccine, the critics also suggested that vaccination 
more generally does not act as an efficient public health measure. For example, Tom Jefferson from the 
Cochrane Institute was called in to provide expert testimony on the case. Dr Jefferson argued that ‘vaccines and 
antivirals have a weak or non-existent evidence base against influenza’.14 Such statements undermined the 
fundamental concept that influenza vaccination is an effective global health action. Likewise, it was argued that 
‘the performance of the [influenza] vaccines in healthy adults is nothing to get excited about’ given that ‘we 
need to vaccinate 100 healthy adults to prevent one set of symptoms’.14 Other public health measures were 
described as having ‘a much better evidence base than vaccines’.14
The strategy of emphasising the lack of efficacy of vaccine use is a key narrative in problematizing vaccination. 
In the case of H1N1, it was suggested that vaccines were a costly and ineffective strategy against the 
pandemic. This uptake of narratives serves to minimise the ‘benefit’ aspect of the risk-to-benefit estimate that 
is central to estimations of the utility of vaccination.
Vaccine Safety
Vaccine hesitancy at the individual level highlights the important role of the relative (perceived) weight of the 
risk of vaccination to the benefits incurred. Perceptions of the severity of the disease being vaccination against 
are weighed up against perceptions of adverse reactions to vaccination. Counter-vaccination movements are 
particularly prone to discourses of risk and uncertainty – vaccines are characterised as unsafe due to the risks 
of severe or lasting medical consequences. Unlike the short term and acute reactions acknowledged by the 
medical community, counter-vaccine narratives commonly emphasise long-term and severe reactions to 
vaccination.
Narratives that problematized vaccine safety were therefore central to the Council of Europe critics’ discussions. 
It was argued that ‘several independent medical experts raised warnings regarding excessive 
vaccination…[where]…there was no clinical scientific evidence to justify this’.11 The safety of vaccination was 
questioned and problematized.
In the case of H1N1, an important point of contention revolved around the novel manufacturing method, which 
was used, it was argued, due to the concern over quickening production and furthering profits. It was suggested 
4PLOS Currents Outbreaks
that the vaccines ‘primarily follow[ed] economic strategies and was not to optimise public health needs’.15 This 
method, it was argued ‘involved higher risks than usual vaccines…[since]…some adjuvants were added and 
injected of which we know, that they stimulate the immune system manifold, which means that they could 
possibly lead to autoimmune diseases (such as multiple sclerosis) and immunological complication’.15
Several other potential adverse effects were cited. For example the ‘fast growing cancer-like cells’ were 
highlighted.15 While such statement were allusions rather than definitive statements, the problematisation of 
vaccine safety was evident in this account. It is also significant, because while (for example) allusions to the 
possible carcinogenic nature of the vaccines was not greatly emphasised within the Council of Europe’s hearing 
on the pandemic, such statements had been mobilised by the media and actors within the anti-vaccination 
movement,15,20,21,22 and may therefore inform wider perceptions about the safety of this vaccine and by 
extension, vaccines more generally.
Conclusions
In order to understand the ways in which individuals make decisions regarding vaccine use, it is important to 
access the public discourse surrounding vaccination. Such narratives incorporate ideas about vaccinations 
which, while contrary to medical and scientific viewpoints, underpins the public understanding of vaccines. As 
such, it is important to see vaccine hesitancy as much a result of public discourse as it is a problem of individual 
decision-making.
The Council of Europe’s criticisms of the use of vaccines during the H1N1 Pandemic reflect many dominant 
discourses – lay understandings of vaccination and public representations of vaccination -that may inform 
vaccine hesitancy. Contestations such as this one, and the ways in which such debates are subsequently picked 
up by the media, have the potential to significantly shape the public discourse. Simultaneously, this debate 
mirrors and mobilises common sentiments surrounding vaccines.
Key to the Council of Europe’s account were three issues: the problem of trust in relation to the decision to use 
vaccines to combat H1N1, the problem of efficacy in terms of vaccines generally and the H1N1 vaccine 
specifically, and the problem of the risk posed by mass vaccination and the safety of the H1N1 vaccines. 
Examining the vaccine counter-narratives provides information that may be considered in addressing vaccine 
hesitancy. Trust building will be central to the task of impacting upon the public debate. Likewise, effective 
communication of issues of risk and trust – in ways that speak directly to the existing public understanding of 
vaccines – is also vital. Consequently it is important to acknowledge vaccine hesitancy as a problem not just of 
the individual level, but critically also of the social.
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